These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36786872)

  • 1. Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.
    Ermeidis C; Dimitroulas T; Pourzitaki C; Voulgari PV; Kouvelas D
    Rheumatol Int; 2023 Jun; 43(6):1151-1159. PubMed ID: 36786872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study.
    Giacomelli R; Gorla R; Trotta F; Tirri R; Grassi W; Bazzichi L; Galeazzi M; Matucci-Cerinic M; Scarpa R; Cantini F; Gerli R; Lapadula G; Sinigaglia L; Ferraccioli G; Olivieri I; Ruscitti P; Sarzi-Puttini P
    Rheumatology (Oxford); 2015 May; 54(5):792-7. PubMed ID: 25288786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Perspectives on Intravenous Biologics for Rheumatologic Disease.
    Grisanti L; Kwiatkowski A; Dyrda P; Field E; Grisanti J; Hatem J; Dehoratius RJ; Gaylis N
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1234-1242. PubMed ID: 30221490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Do Patients with Chronic Inflammatory Rheumatic Diseases Discontinue Their Biologics? An Assessment of Patients' Adherence Using a Self-report Questionnaire.
    Betegnie AL; Gauchet A; Lehmann A; Grange L; Roustit M; Baudrant M; Bedouch P; Allenet B
    J Rheumatol; 2016 Apr; 43(4):724-30. PubMed ID: 26879361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rheumatoid arthritis in Turkey: a questionnaire study.
    Direskeneli H; Akkoç N; Bes C; Cakir N; Cefle A; Cobankara V; Dalkilic E; Dinc A; Ertenli I; Gul A; Hamuryudan V; Inanc M; Kalyoncu U; Karaaslan Y; Kasifoglu T; Keser G; Keskin G; Kisacik B; Kiraz S; Masatlioglu S; Onat AM; Ozbek S; Ozturk MA; Pamuk ON; Pay S; Pirildar T; Sayarlioglu M; Senel S; Senturk T; Tasan D; Terzioglu E; Yazici A; Yucel E
    Clin Exp Rheumatol; 2014; 32(4):477-83. PubMed ID: 24960289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services.
    Sanders L; Donovan-Hall M; Borthwick A; Bowen CJ
    J Foot Ankle Res; 2017; 10():14. PubMed ID: 28331550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Mok CC; Ho LY; Tse SM; Chan KL; To CH
    Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy.
    Raghunath S; Hijjawi R; Hoon E; Shanahan EM; Goldblatt F
    Clin Rheumatol; 2019 Oct; 38(10):2699-2707. PubMed ID: 31172365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
    Alves de Oliveira Junior H; Pereira da Veiga T; Acurcio FA; Almeida AM; Ribeiro Dos Santos JB; da Silva MRR; Kakehasi AM; Cherchiglia ML
    Hosp Pract (1995); 2020 Oct; 48(4):213-222. PubMed ID: 32567403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of patients with rheumatic diseases treated with subcutaneous biologicals on their level of information: RHEU-LIFE Survey.
    de Toro J; Cea-Calvo L; Battle E; Carmona L; Arteaga MJ; Fernández S; González CM
    Reumatol Clin (Engl Ed); 2019; 15(6):343-349. PubMed ID: 29277578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of patient and physician treatment satisfaction in moderate-to-severe psoriasis: a multinational survey of psoriasis patients.
    Teeple A; Villacorta R; PharmD SL; Fakharzadeh S; Lucas J; PhD NL
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of health-related quality of life between patients with rheumatic diseases and a control group].
    Rugiene R; Dadoniene J; Venalis A; Stropuviene S
    Medicina (Kaunas); 2005; 41(7):561-5. PubMed ID: 16062023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
    Kim MJ; Lee EB; Song YW; Park JK
    Clin Rheumatol; 2020 Oct; 39(10):2899-2906. PubMed ID: 32314175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspective of a dedicated biologic clinic for inflammatory arthritis.
    Cefai E; Balzan D; Mercieca C; Borg A
    Int J Health Care Qual Assur; 2019 Jun; 32(5):879-886. PubMed ID: 31195927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient- and Physician-reported Satisfaction With Systemic Lupus Erythematosus Treatment in US Clinical Practice.
    Pascoe K; Lobosco S; Bell D; Hoskin B; Chang DJ; Pobiner B; Ramachandran S
    Clin Ther; 2017 Sep; 39(9):1811-1826. PubMed ID: 28803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America.
    Alves Pereira I; Maldonado Cocco J; Feijó Azevedo V; Guerra G; Bautista-Molano W; Casasola JC; Vega Morales D; Soriano ER; Gil DR; Zazzetti F; Aldunate L; Holdsworth EA; Massey O; Lobosco S; Lawson F
    Clin Rheumatol; 2020 Jun; 39(6):1813-1822. PubMed ID: 32030635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.
    De Mits S; Lenaerts J; Vander Cruyssen B; Mielants H; Westhovens R; Durez P; Elewaut D;
    PLoS One; 2016; 11(11):e0166607. PubMed ID: 27893771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.